These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Granular biodurable nanomaterials: No convincing evidence for systemic toxicity. Moreno-Horn M; Gebel T Crit Rev Toxicol; 2014 Nov; 44(10):849-75. PubMed ID: 25257841 [TBL] [Abstract][Full Text] [Related]
65. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale. Halappanavar S; van den Brule S; Nymark P; Gaté L; Seidel C; Valentino S; Zhernovkov V; Høgh Danielsen P; De Vizcaya A; Wolff H; Stöger T; Boyadziev A; Poulsen SS; Sørli JB; Vogel U Part Fibre Toxicol; 2020 May; 17(1):16. PubMed ID: 32450889 [TBL] [Abstract][Full Text] [Related]
66. Sameness: The regulatory crux with nanomaterial identity and grouping schemes for hazard assessment. Walser T; Studer C Regul Toxicol Pharmacol; 2015 Aug; 72(3):569-71. PubMed ID: 26049104 [TBL] [Abstract][Full Text] [Related]
67. In vitro assessments of nanomaterial toxicity. Jones CF; Grainger DW Adv Drug Deliv Rev; 2009 Jun; 61(6):438-56. PubMed ID: 19383522 [TBL] [Abstract][Full Text] [Related]
68. The status of in vitro toxicity studies in the risk assessment of nanomaterials. Park MV; Lankveld DP; van Loveren H; de Jong WH Nanomedicine (Lond); 2009 Aug; 4(6):669-85. PubMed ID: 19663595 [TBL] [Abstract][Full Text] [Related]
74. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials. Card JW; Jonaitis TS; Tafazoli S; Magnuson BA Crit Rev Toxicol; 2011 Jan; 41(1):22-49. PubMed ID: 21077788 [TBL] [Abstract][Full Text] [Related]
76. [Management and safety assessment of nanomaterials in food: status and prospects]. Li ZQ; Zheng WW; Liu Y; Zhou Y; He GS; Zheng YX; Qu WD Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Oct; 52(10):1082-1088. PubMed ID: 30392333 [TBL] [Abstract][Full Text] [Related]
77. The primacy of physicochemical characterization of nanomaterials for reliable toxicity assessment: a review of the zebrafish nanotoxicology model. Bohnsack JP; Assemi S; Miller JD; Furgeson DY Methods Mol Biol; 2012; 926():261-316. PubMed ID: 22975971 [TBL] [Abstract][Full Text] [Related]
78. Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling. Lubinski L; Urbaszek P; Gajewicz A; Cronin MT; Enoch SJ; Madden JC; Leszczynska D; Leszczynski J; Puzyn T SAR QSAR Environ Res; 2013; 24(12):995-1008. PubMed ID: 24313439 [TBL] [Abstract][Full Text] [Related]
79. Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Joris F; Manshian BB; Peynshaert K; De Smedt SC; Braeckmans K; Soenen SJ Chem Soc Rev; 2013 Nov; 42(21):8339-59. PubMed ID: 23877583 [TBL] [Abstract][Full Text] [Related]
80. Drosophila melanogaster as a model organism to study nanotoxicity. Ong C; Yung LY; Cai Y; Bay BH; Baeg GH Nanotoxicology; 2015 May; 9(3):396-403. PubMed ID: 25051331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]